Bill > HR4570

This bill establishes an Interagency Task Force on Patents between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) to improve coordination and information sharing regarding patents for human drugs and biological products. The task force will be composed of employees from both agencies with relevant expertise, who will work together to share information about their review processes, patent approvals, new technologies, and scientific developments. Key provisions include creating a mechanism for the USPTO to request and receive information from the FDA about drug approvals and product information that could be relevant to patent examinations, establishing protocols for confidential information sharing, and requiring the USPTO Director to submit a report to Congress within four years detailing the task force's activities and effectiveness. The bill aims to enhance the patent examination process by allowing patent examiners to access more comprehensive information, while also implementing strict confidentiality safeguards to protect sensitive data. The task force will facilitate routine meetings, workshops, and information exchanges between the two agencies to promote more accurate and informed patent decisions related to pharmaceuticals.

Justice

https://www.congress.gov/bill/119th-congress/house-bill/4570/all-info